50th week of 2017 patent applcation highlights part 6 |
Patent application number | Title | Published |
20170354576 | THE AMPHIPHILIC POLYMER | 2017-12-14 |
20170354577 | Oral Care Products and Methods of Use and Manufacture Thereof | 2017-12-14 |
20170354578 | Preparation of Zinc Citrate and of Zinc Citrate-Containing Oral Care Compositions | 2017-12-14 |
20170354579 | DYE COMPOSITION COMPRISING A PARA-PHENYLENEDIAMINE OXIDATION BASE AND AN AMPHOTERIC OR CATIONIC POLYMER IN A MEDIUM RICH IN FATTY SUBSTANCES | 2017-12-14 |
20170354580 | DYE COMPOSITION COMPRISING A PARA-PHENYLENEDIAMINE OXIDATION BASE AND A HETEROCYCLIC OXIDATION BASE | 2017-12-14 |
20170354581 | COMPOSITION FOR COLOURING HAIR | 2017-12-14 |
20170354582 | COMPOSITIONS AND METHODS FOR TREATING HAIR LOSS AND DELAYING AGING OF SKIN | 2017-12-14 |
20170354583 | DIRECT DYEING AGENTS IN FOAM FORM | 2017-12-14 |
20170354584 | HAIR DYEING PROCESS USING AT LEAST ONE DYE, AN ORGANIC TITANIUM SALT, AND A NON-CELLULOSIC-BASED POLYSACCHARIDE | 2017-12-14 |
20170354585 | NON-COMEDOGENIC AND NON-ACNEGENIC HAIR AND SCALP CARE FORMULATIONS AND METHOD FOR USE | 2017-12-14 |
20170354586 | HAIR CARE COMPOSITIONS CONTAINING CATIONIC POLYMERS | 2017-12-14 |
20170354587 | COMPOSITIONS COMPRISING AN AUTOASSOCIATIVE POLYURETHANE, A FATTY ALCOHOL OR ACID, A NONIONIC SURFACTANT, AND A PIGMENT | 2017-12-14 |
20170354588 | LONGWEARING COMPOSITION FOR KERATINOUS FIBER | 2017-12-14 |
20170354589 | HYDRATING LIP BALM COMPOSITION | 2017-12-14 |
20170354590 | SKIN TIGHTENING LOTION | 2017-12-14 |
20170354591 | COMPOSITIONS FOR USE WITH A FASCIA TISSUE TREATMENT DEVICE TO REDUCE CELLULITE | 2017-12-14 |
20170354592 | PARENTERAL SUSTAINED-RELEASE DELIVERY OF CARVEDILOL DISPERSE SYSTEMS | 2017-12-14 |
20170354593 | PALATABLE CHEWABLE VETERINARY COMPOSITION | 2017-12-14 |
20170354594 | PROTEASE COMPOSITIONS FOR USE IN MODIFYING SEMEN | 2017-12-14 |
20170354595 | TRANSDERMAL SILICONE GEL (SILOGEL) COMPOSITIONS AND METHODS OF PREPARATION | 2017-12-14 |
20170354596 | OIL-IN-WATER NANOEMULSIONS | 2017-12-14 |
20170354597 | NONSTEROIDAL IMMUNOMODULATING KIT AND COMPOSITION AND USES THEREOF | 2017-12-14 |
20170354598 | EXTERNAL COMPOSITION FOR SCREEN FOAMERS | 2017-12-14 |
20170354599 | LIPID MULTIPARTICULATE FORMULATIONS | 2017-12-14 |
20170354600 | COMPOSITION AND METHOD FOR STABILIZING GSH | 2017-12-14 |
20170354601 | ION IMPLANTATION OF MAGNETIC ELEMENTS INTO NANODIAMOND PARTICLES TO FORM COMPOSITION FOR MEDICAL USAGE | 2017-12-14 |
20170354602 | Use of Simple Amino Acids to Form Porous Particles | 2017-12-14 |
20170354604 | Oral Tablet Formulation Consisting Of Fixed Combination Of Rosuvastatin And Ezetimibe For Treatment Of Hyperlipidemia And Cardiovascular Diseases | 2017-12-14 |
20170354605 | DRUG DELIVERY SYSTEM | 2017-12-14 |
20170354606 | Process for Making Tablet Using Radiofrequency and Lossy Coated Particles | 2017-12-14 |
20170354608 | COATING AGENT CONTAINING NANO-SIO2 AND A PREPARATION METHOD THEREOF | 2017-12-14 |
20170354609 | PHARMACEUTICAL TABLET COATING PROCESS BY INJECTION MOLDING PROCESS TECHNOLOGY | 2017-12-14 |
20170354610 | MICROCELLULAR MICROSTRUCTURE AND METHOD FOR MANUFACTURING SAME | 2017-12-14 |
20170354611 | Multilayer Biodegradable Microparticles for Sustained Release of Therapeutic Agents | 2017-12-14 |
20170354612 | Process for forming a substance with a superstructure and Application Thereof | 2017-12-14 |
20170354613 | STEALTH NANOCAPSULES FOR PROTEIN DELIVERY | 2017-12-14 |
20170354614 | PREPARATION | 2017-12-14 |
20170354615 | PHARMACEUTICAL PREPARATION | 2017-12-14 |
20170354616 | ONYCHOMYCOSIS TREATMENT SYSTEM AND METHOD | 2017-12-14 |
20170354617 | METHOD OF TREATING OR PREVENTING OSTEOPOROSIS | 2017-12-14 |
20170354618 | FORMULATIONS OF QUINONES FOR THE TREATMENT OF OPHTHALMIC DISEASES | 2017-12-14 |
20170354619 | BUPROPION AS A MODULATOR OF DRUG ACTIVITY | 2017-12-14 |
20170354620 | SUBSTITUTED PYRIDYL-CYCLOALKYL-CARBOXYLIC ACIDS, COMPOSITIONS CONTAINING THEM AND MEDICAL USES THEREOF | 2017-12-14 |
20170354621 | SULFONAMIDE PHARMACEUTICAL COMPOSITION | 2017-12-14 |
20170354622 | NOVEL BENZENESULFONAMIDE COMPOSITIONS FOR TREATMENT OF MALIGNANT PLEURAL EFFUSIONS | 2017-12-14 |
20170354623 | RECEPTOR SUBTYPE AND FUNCTION SELECTIVE RETINOID AND REXINOID COMPOUNDS IN COMBINATION WITH IMMUNE MODULATORS FOR CANCER IMMUNOTHERAPY | 2017-12-14 |
20170354624 | TOPICAL COMPOSITIONS FOR TREATMENT OF SKIN IRRITATION | 2017-12-14 |
20170354625 | Controlled Release Dosage Form | 2017-12-14 |
20170354626 | COMPOSITION FOR DECREASING HEMATOPOIETIC STEM CELLS, AND METHOD FOR PRODUCING SAME | 2017-12-14 |
20170354627 | TREATMENT OF DISEASES ASSOCIATED WITH HEPATIC STELLATE CELL ACTIVATION USING AMMONIA-LOWERING THERAPIES | 2017-12-14 |
20170354628 | METHOD OF TREATING OBESITY WITH CHLOROGENIC ACID | 2017-12-14 |
20170354629 | Method And Compositions For Treating Skin | 2017-12-14 |
20170354630 | Methods of Treating Multiple Sclerosis | 2017-12-14 |
20170354631 | METHODS OF TREATING UREA CYCLE DISORDERS | 2017-12-14 |
20170354632 | METHODS OF TREATING UREA CYCLE DISORDERS | 2017-12-14 |
20170354633 | APPLICATION OF DERIVATIVE OF CLOSTRIDIUM GHONII | 2017-12-14 |
20170354634 | COMBINATIONS OF PROSTAGLANDINS AND NITRIC OXIDE DONORS | 2017-12-14 |
20170354635 | METHODS FOR TREATING ATRIAL FIBRILLATION | 2017-12-14 |
20170354636 | METHODS FOR INHIBITING TUMORS AND DRUG RESISTANCE | 2017-12-14 |
20170354637 | FIBROTIC TISSUE STABILIZED BY CROSSLINKING FOR TREATMENT OF SNORING AND OBSTRUCTIVE SLEEP APNEA | 2017-12-14 |
20170354638 | BIXA ORELLANA COMPOSITION FOR THE TREATMENT MACULAR DEGENERATION | 2017-12-14 |
20170354639 | DITERPENOID DERIVATIVES AND METHODS OF USE THEREOF | 2017-12-14 |
20170354640 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF PRE-DIABETES, DIABETES AND METABOLIC SYNDROME | 2017-12-14 |
20170354641 | 2,3-DIHYDRO-1H-INDOLE COMPOUNDS | 2017-12-14 |
20170354642 | ENVENOMATION THERAPIES AND RELATED PHARMACEUTICAL COMPOSITIONS, SYSTEMS AND KITS | 2017-12-14 |
20170354643 | TRIFLUOROMETHYL PYRAZOLYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF | 2017-12-14 |
20170354644 | Polymorphic Forms of Methyl((1S)-1-(((2S)-2-(5-(4'-(2-((2S)-1-((2S)-2-((methoxycarbonyl)amino)- -3-methylbutanoyl)-2-pyrrolidinyl)-1H-imidazol-5-yl)-4-biphenylyl)-1H-imid- azol-2-yl)-1-pyrrolidinyl) carbonyl)-2-methylpropyl)carbamate and Salts Thereof | 2017-12-14 |
20170354645 | METHODS FOR TREATING KIDNEY DISORDERS | 2017-12-14 |
20170354646 | METHOD FOR TREATING DISORDERS ASSOCIATED WITH GLOMERULAR FUNCTION | 2017-12-14 |
20170354647 | Use of Metformin in Combination with a Glucokinase Activator and Compositions Comprising Metformin and a Glucokinase Activator | 2017-12-14 |
20170354648 | 1,9-DIAZASPIRO UNDECANE COMPOUNDS HAVING MULTIMODAL ACTIVITY AGAINST PAIN | 2017-12-14 |
20170354649 | THERAPEUTIC USES OF BERBERINE FORMULATIONS | 2017-12-14 |
20170354650 | QUINOLINE DERIVATIVES FOR INHIBITING HISTONE METHYLTRANSFERASES AND USE THEREOF | 2017-12-14 |
20170354651 | Treatment Of Neurodegenerative Diseases With Combination Of Laquinimod And Fingolimod | 2017-12-14 |
20170354652 | ENHANCEMENT OF IMPAIRED MOTOR AND MENTAL FUNCTIONS, USING DEXTROMETHORPHAN AND OXIDASE ENZYME INHIBITOR | 2017-12-14 |
20170354653 | BUPRENORPHINE DOSING REGIMENS | 2017-12-14 |
20170354655 | TLR INHIBITOR AND BRUTON'S TYROSINE KINASE INHIBITOR COMBINATIONS | 2017-12-14 |
20170354656 | Quinazoline Compounds | 2017-12-14 |
20170354657 | METHOD OF TREATING PANCREATIC CANCER | 2017-12-14 |
20170354658 | FORMULATION INHIBITING EFFECTS OF LOW ACID ENVIRONMENT | 2017-12-14 |
20170354659 | COMPOSITIONS CONTAINING DEFINED CAFFEINE AND THEOBROMINE LEVELS WITH ENHANCED COGNITIVE PROPERTIES | 2017-12-14 |
20170354660 | Medical Use of Pharmaceutical Combination or Composition | 2017-12-14 |
20170354662 | METHODS AND COMPOSITIONS FOR TREATING MIGRAINES USING NORIBOGAINE | 2017-12-14 |
20170354663 | Steroidal Compositions | 2017-12-14 |
20170354664 | Prodrugs of 17.BETA.-HSD1-inhibitors | 2017-12-14 |
20170354665 | Abiraterone Acetate Formulation | 2017-12-14 |
20170354666 | COMPOSITIONS AND METHODS FOR TREATING LYSOSOMAL DISORDERS | 2017-12-14 |
20170354667 | COMPOSITION AND METHOD FOR TREATING BIPOLAR DISORDER | 2017-12-14 |
20170354668 | Synthesis Method For Improved Tenofovir Disoproxil Fumarate Using Ion-Exchange Resin And Method For Preparing Oral Dissolving Film Form Using The Same | 2017-12-14 |
20170354669 | DISRUPTION OF THE INTERACTION BETWEEN AMYLOID BETA PEPTIDE AND DIETARY LIPIDS | 2017-12-14 |
20170354670 | PRODUCT COMPRISING GLUCOSAMINE FOR EXTERNAL APPLICATION | 2017-12-14 |
20170354671 | TREATMENT OF OCULAR DISORDERS | 2017-12-14 |
20170354672 | COMPOSITIONS FOR THE DELIVERY OF TRNA AS NANOPARTICLES AND METHODS OF USE THEREWITH | 2017-12-14 |
20170354673 | OLIGONUCLEOTIDE HAVING NON-NATURAL NUCLEOTIDE AT 5'-TERMINAL THEREOF | 2017-12-14 |
20170354674 | ADMINISTRATION OF SYNERGISTIC AMOUNTS OF MODIFIED CITRUS PECTIN AND HONOKIOL TO TREAT INFLAMMATION AND ANTI-OXIDANT NEEDS | 2017-12-14 |
20170354675 | CHONDROITIN SULFATE DERIVATIVE AND AGENT FOR TREATING BLADDER DISEASES | 2017-12-14 |
20170354676 | Composition for the Relief of Dry Mouth | 2017-12-14 |
20170354677 | MAGNESIUM DELIVERY SYSTEM | 2017-12-14 |
20170354678 | Use of the mixture of a salt and sugar in the manufacture of a medicament employed for treating Lax vagina syndrome or colpoxerosis disease in an mammal | 2017-12-14 |
20170354679 | Mixture of processed salt and sugar in the manufacture of a medicament employed for treating Lax vegina syndrome or colpoxerosis disease in an mammal | 2017-12-14 |